Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
The current price of Abbott Laboratories in the market is 912,42 kr, with a 24-hour trading volume of 122,26K kr. The asset's market cap is 1,58T kr, after moving 0.35% in the last day.
Tokenized Abbott Laboratories is trading at 917,41 kr, with a tokenized market cap of 301,69M kr and a 24-hour trading volume of 14,45M kr. The tokenized asset has moved 0.93% in the past 24 hours.